Skip to main content
. Author manuscript; available in PMC: 2023 Feb 14.
Published in final edited form as: Biomed J Sci Tech Res. 2022 Feb 14;41(5):33086–33092. doi: 10.26717/BJSTR.2022.41.006668

Table 2:

Imaging characteristics including modality that resulted in BIRADS 3, lesion location and lesion morphology, and follow-up.

Characteristic Value (%)
Modality
Mammogram & Ultrasound 590/1,037 (56.9%)
Mammogram alone 404/1,037 (39.0%)
Ultrasound alone 41/1,037 (3.95%)
Laterality
Left 462/1,037 (44.6%)
Right 516/1,037 (49.8%)
Both 59/1,037 (5.7%)
Morphology
Asymmetry/ Architectural Distortion 512/1,037 (49%)
Grouped calcifications 398/1,037 (38%)
Noncalcified circumscribed mass 90/1,037 (9%)
Other 37/1,037 (4%)
Follow-up rates *
At 6 months 1,007/1,037 (97.1%)
At 12 months 979/1,022 (95.8%)
At 18-24 months 876/1,011 (86.7%)
*

Denominator adjusted for benign pathology from biopsy at prior follow-up.